SCHEMBL6566633

SCHEMBL6566633

COC(=O)c1cc(NC(=O)Nc2ccc(OC)c(OC)c2)ccc1OC(c1ccc(F)cc1)c1cccc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.49
KMT2A Q03164 10/20 0.49
MAPT P10636 8/20 0.49
LMNA P02545 4/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
POLB P06746 1/20 0.46
TP53 P04637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
RAB9A P51151 4/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 3/20 0.42
ATM Q13315 1/20 0.42
CASP3 P42574 1/20 0.41
SENP7 Q9BQF6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567726 0.93 MAPT (0.51) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6567855 0.93 MEN1 (0.53) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6565909 0.92 MEN1 (0.49) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6567777 0.91 MAPT (0.45) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6565683 0.91 KMT2A (0.50) MEN1KMT2AMAPTLMNATP53
SCHEMBL6565825 0.91 KMT2A (0.54) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6568055 0.90 MAPT (0.47) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6566572 0.89 POLB (0.43) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6566991 0.88 KMT2A (0.51) MEN1KMT2AMAPTLMNAHTT
SCHEMBL6566965 0.87 MEN1 (0.51) MEN1KMT2AMAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MEN1 4143/4885KMT2A 3137/4885MAPT 4743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.